PRODRUGS IN CANCER-CHEMOTHERAPY

被引：20

作者：

CONNORS, TA

机构：

来源：

XENOBIOTICA | 1986年 / 16卷 / 10-11期

关键词：

D O I：

10.3109/00498258609038977

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：975 / 988

页数：14

共 36 条

[1] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 5'-SUBSTITUTED 5-FLUOROPYRIMIDINE NUCLEOSIDES [J].

AJMERA, S ;

DANENBERG, PV .

JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (08) :999-1002

[2] FORMATION OF CYTOTOXIC ALDEHYDE ACROLEIN DURING IN-VITRO DEGRADATION OF CYCLOPHOSPHAMIDE [J].

ALARCON, RA ;

MEIENHOF.J .

NATURE-NEW BIOLOGY, 1971, 233 (42) :250-&

[3]

AOSHIMA M, 1977, CANCER RES, V37, P2481

[4] NEUARTIGE KREBS-CHEMOTHERAPEUTIKA AUS DER GRUPPE DER ZYKLISCHEN N-LOST-PHOSPHAMIDESTER [J].

ARNOLD, H ;

BOURSEAUX, F ;

BROCK, N .

NATURWISSENSCHAFTEN, 1958, 45 (03) :64-66

[5]

AU JLS, 1983, BIOCHEM PHARMACOL, V32, P541

[6] STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPY [J].

BARDOS, TJ ;

CHMIELEWICZ, ZF ;

HEBBORN, P .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1969, 163 (A2) :1006-+

[7]

BEISLER KA, 1978, J MED CHEM, P204

[8]

BROCK N, 1983, STRUCTURE ACTIVITY R, P239

[9] CYTOTOXIC AGENTS DESIGNED TO BE SELECTIVE FOR LIVER CANCER [J].

BUKHARI, A ;

CONNORS, TA ;

GILSENAN, AM ;

ROSS, WCJ ;

TISDALE, MJ ;

WARWICK, GP ;

WILMAN, DEV .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 50 (01) :243-247

[10]

CHAKRAVARTY PK, 1983, J MED CHEM, V26, P663

← 1 2 3 4 →